Clinical Trial Update: A Phase 2 Study of RO7490677 In Participants With Myelofibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RO7490677 in myeloproliferative neoplasms has completed; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelofibrosis
• Polycythemia Vera
• Post-essential Thrombocythemia Myelofibrosis

Drugs mentioned

• RO7490677

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Primary Myelofibrosis, Polycythemia Vera | Phase 2 | Status: COMPLETED | Results posted: 2022-01-05